Atlanta, Georgia: The American Cancer Society, (2014) . Available online. 2 Ploeg M, Aben K and Kiemeney L . (2009). The present and future burden of urinary bladder cancer in the world. World J. Urol . 27(3), 289 -293. 3 Botteman MF, Pashos CL, Redaelli A, et al. (2003) The health economics of bladder cancer: a comprehensive review of the published literature. Pharmaco Economics 21(18): 1315 -1330. 4 Avritscher EBC, Cooksley CD, Grossman HB et al. (2006) Cl inical model of lifetime cost of treating bladder cancer and associated complications. Urology 68(3):549 -553. 5 Barocas D, Globe D, Colayco D, et al. (2012) Surveillance and treatment of non -muscle -invasive bladder cancer in the USA. Advances in Urology , Article ID 421709, 8 pages 6 van Rhijn B, Burger M, Lotan Y, et al (2009). Recurrence and progression of disease in non -muscle -invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol . 56(3), 430 -442. 7 Lamm D, Colombel M, Persad R, et al. (2008) Clinical practice recommendations for the management of non - muscle invasive bladder cancer. Eur. Urol. Supp . 7, 651 -666. 8 Kamat AM, Witjes JA, Brausi M, et al. (2014) Defining and treating the spectrum of intermediate risk nonmuscle invasive bladd er cancer. J. Urol . [Epub ahead of print] 9 Bono AV, Benvenuti C, Gibba A, et al. Adjuvant chemotherapy in locally advanced bladder cancer. Final analysis of a controlled multicentre study. Acta Urol Ital . 1997;11(1):5 –8. 10 Vale CL. Adjuvant chemotherapy for invasive bladder cancer (individual patient data). Cochrane Database of Systematic Reviews . 2006, Issue 2. Art. No.: CD006018. 11 HerrHW, Dalbagni G, and Donat SM. (2011) Bacillus Calmet -Guérin without maintenance therapy for high -risk non-muscle -invasive bladder cancer. Eur. Urol . 60(1):32 -36. 12 Lamm DL, Blumenstein BA, Crissman JD, et al. (2000) Maintenance bacillus Calmette -Guérin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study. J.